🏥 治験ポータル
← 治験一覧に戻る

頭頸部がんに対する線量最適化BNCT

基本情報

NCT ID
NCT05883007
ステータス
不明
試験のフェーズ
第1相
試験タイプ
介入
目標被験者数
30
治験依頼者名
Southern Tohoku BNCT Research Center

概要

The goal of this clinical trial is to evaluate the safety of applying BNCT with the dose optimization in patients with recurrent head and neck cancer. The main questions it aims to answer are: \- Dose optimized BNCT are conducted safety in these patients. Participants will receive dose optimized BNCT regulated as 12, 15, 18 Gy-Eq of the mucosal dose.

対象疾患

Head and Neck CancerSquamous Cell Carcinoma

介入

Accelerator-based BNCT with borofalan(10B)(RADIATION)

依頼者(Sponsor)

実施施設 (1)

総合南東北病院

Kōriyama, Fukushima, Japan